Anebulo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 92.4% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.3%	Joseph Lawler	12,000,000	€20.9m	0%	no data
20.7%	22NW, LP	5,366,290	€9.3m	0%	8.29%
18%	Aron English	4,654,528	€8.1m	0%	no data
2.48%	LVW Advisors, LLC	642,039	€1.1m	0%	0.18%
1.97%	Nantahala Capital Management, LLC	511,073	€889.4k	0%	0.09%
1.54%	Morgan Stanley, Investment Banking and Brokerage Investments	399,219	€694.7k	0%	no data
0.61%	Ikarian Capital, LLC	157,862	€274.7k	0%	0.09%
0.59%	The Vanguard Group, Inc.	153,873	€267.8k	0.26%	no data
0.2%	Geode Capital Management, LLC	51,308	€89.3k	125%	no data
0.073%	Boothbay Fund Management, LLC	18,978	€33.0k	0%	no data
0.015%	BlackRock, Inc.	3,761	€6.5k	-7.11%	no data
0.013%	Tower Research Capital Europe Limited	3,300	€5.7k	-35.8%	no data
0.0014%	Lord, Abbett & Co. LLC	366	€636.3	0%	no data
0.00025%	Bank of America Corporation, Asset Management Arm	65	€112.8	0%	no data
0.0002%	Royal Bank of Canada, Banking & Securities Investments	51	€90.3	34.2%	no data
0.00004%	JPMorgan Chase & Co, Brokerage and Securities Investments	10	€18.1	11.1%	no data